A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors
Clinical trial NCT03707340 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03707340
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2026-10-14
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.